A life sciences infrastructure platform called Rx Propellant is dedicated to establishing manufacturing and research clusters in India. Bangalore and Hyderabad are where it conducts business. It launched several initiatives at Genome Valley in October of last year, totaling roughly Rs 900 crore in funding. Vice-president of Rx Propellant Ketki Tulpule talks to B Krishna Mohan about the business’s operations. “We have a portfolio of about 5 million sqft spanning multiple projects in Genome Valley (Hyderabad) and Bengaluru. The platform offers an ‘asset-light’ proposition for organisations to scale up,” he said.

Buy Latest Research Reports